Search Result "SB203580"

Research Article

Combined Treatment with CCI779 and SB203580 Induces Cellular Senescence in Renal Cell Carcinoma Cell Line via p53 Pathway

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2017 Page: 1545-1554
Author(s): Ashutosh Chauhan, Rani Ojha, Deepak K. Semwal, Satyendra P. Mishra, Ruchi B. Semwal

Selectivity of SB203580, SB202190 and Other Commonly Used p38 Inhibitors: Profiling Against a Multi-Enzyme Panel

Journal: Letters in Drug Design & Discovery
Volume: 2 Issue: 7 Year: 2005 Page: 516-521
Author(s): Jacqueline L. Norris, Kevin P. Williams, William P. Janzen, C. N. Hodge, Leonard J. Blackwell, Ioana G. Popa-Burke

Development and Optimization of a Non-Radioactive JNK3 Assay

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 9 Issue: 8 Year: 2006 Page: 613-618
Author(s): Christian Peifer, Sabine Luik, Sabine Thuma, Yvonne Herweh, Stefan Laufer

Pharmacophore Design of p38α MAP Kinase Inhibitors with Either 2,4,5-Trisubstituted or 1,2,4,5-Tetrasubstituted Imidazole Scaffold

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1526-1539
Author(s): T. Scior, D. M. Domeyer, K. Cuanalo-Contreras, S. A. Laufer

The Non-Diaryl Heterocycle Classes of p38 MAP Kinase Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 2 Issue: 9 Year: 2002 Page: 1021-1035
Author(s): Pier F. Cirillo, Christopher Pargellis, John Regan

p38 MAP Kinase Inhibitors as Anti inflammatory Agents

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 2082-2096
Author(s): Mohammad Amir, K. Somakala, Sazid Ali

Hydroxytyrosol Promotes Superoxide Production and Defects in Autophagy Leading to Anti-proliferation and Apoptosis on Human Prostate Cancer Cells

Journal: Current Cancer Drug Targets
Volume: 13 Issue: 6 Year: 2013 Page: 625-639
Author(s): Cheng Luo, Yan Li, Hui Wang, Yang Cui, Zhihui Feng, Hua Li, Yuan Li, Ying Wang, Karin Wurtz, Peter Weber, Jiangang Long, Jiankang Liu

General Research Article

2-Methoxy-6-Acetyl-7-Methyljuglone (MAM) Induces iNOS/NO-mediated DNA Damage Response through Activation of MAPKs Pathways

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 6 Year: 2018 Page: 903-913
Author(s): Yanan Niu,Renyikun Yuan,Hongwei Gao,Qi Kong,Jin-Jian Lu,Xiuping Chen

p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 45-59
Author(s): S. Yasuda, H. Sugiura, H. Tanaka, S. Takigami, K. Yamagata

P38 MAPK Contributes to Resistance and Invasiveness of HER2- Overexpressing Breast Cancer

Journal: Current Medicinal Chemistry
Volume: 21 Issue: 4 Year: 2014 Page: 501-510
Author(s): S.M. Donnelly, E. Paplomata, B.M. Peake, E. Sanabria, Z. Chen, R. Nahta

Previous   Next

Go To   Results 1 - 1 of 251

Filter Result

Volume Year
© 2022 Bentham Science Publishers | Privacy Policy